| __timestamp | BioMarin Pharmaceutical Inc. | Iovance Biotherapeutics, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 129764000 | 9335772 |
| Thursday, January 1, 2015 | 152008000 | 999000 |
| Friday, January 1, 2016 | 209620000 | 978000 |
| Sunday, January 1, 2017 | 241786000 | 952000 |
| Monday, January 1, 2018 | 315264000 | 956000 |
| Tuesday, January 1, 2019 | 359466000 | 8122999 |
| Wednesday, January 1, 2020 | 524272000 | 8712000 |
| Friday, January 1, 2021 | 470515000 | 13980000 |
| Saturday, January 1, 2022 | 483669000 | 21135000 |
| Sunday, January 1, 2023 | 577065000 | 10755000 |
| Monday, January 1, 2024 | 580235000 |
In pursuit of knowledge
In the ever-evolving world of biotechnology, cost efficiency is a critical metric for success. Over the past decade, BioMarin Pharmaceutical Inc. and Iovance Biotherapeutics, Inc. have showcased contrasting trajectories in managing their cost of revenue. From 2014 to 2023, BioMarin's cost of revenue surged by approximately 345%, reflecting its expansive growth and increased operational scale. In contrast, Iovance's cost of revenue remained relatively stable, with a modest increase of around 15% over the same period.
BioMarin's peak in 2023, with costs reaching nearly 578 million, underscores its aggressive market strategies and product development. Meanwhile, Iovance's consistent cost management, peaking at just over 21 million in 2022, highlights its focus on lean operations. This comparison not only illustrates the diverse strategies within the biotech sector but also emphasizes the importance of cost management in sustaining long-term growth.
Cost of Revenue Comparison: Teva Pharmaceutical Industries Limited vs BioMarin Pharmaceutical Inc.
Cost of Revenue Trends: BeiGene, Ltd. vs BioMarin Pharmaceutical Inc.
Cost Insights: Breaking Down Incyte Corporation and BioMarin Pharmaceutical Inc.'s Expenses
Comparing Cost of Revenue Efficiency: BioMarin Pharmaceutical Inc. vs PTC Therapeutics, Inc.
BioMarin Pharmaceutical Inc. vs Ligand Pharmaceuticals Incorporated: Efficiency in Cost of Revenue Explored
Cost of Revenue Comparison: BioMarin Pharmaceutical Inc. vs Wave Life Sciences Ltd.
Analyzing Cost of Revenue: BioMarin Pharmaceutical Inc. and Galapagos NV
BioMarin Pharmaceutical Inc. vs BioCryst Pharmaceuticals, Inc.: Efficiency in Cost of Revenue Explored
Cost of Revenue Trends: Telix Pharmaceuticals Limited vs Iovance Biotherapeutics, Inc.
Cost Insights: Breaking Down Ionis Pharmaceuticals, Inc. and Iovance Biotherapeutics, Inc.'s Expenses
Analyzing Cost of Revenue: ACADIA Pharmaceuticals Inc. and Iovance Biotherapeutics, Inc.
Cost of Revenue Trends: Bausch Health Companies Inc. vs Iovance Biotherapeutics, Inc.